Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AKTX — Akari Therapeutics Plc

CIK 1423053 MIAMI, FL
Back to AKTX Full portfolio

Position in AKTX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
-$98,117 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
8 quarters on record

Common Shares in AKTX Over Time

Shares Held

Position Value (USD)

Derivatives in AKTX

reported options exposure · as of Jun 30, 2026
CallValue
$102,450
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in AKTX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $102,450 10,000
2024-09-30 $98,117 33,260
2022-12-31 $7,259 15,446
2022-06-30 $15,064 15,064
2021-09-30 $61,565 37,770
2021-06-30 $90,418 52,265
2021-03-31 $73,159 27,712
2020-06-30 $41,326 18,957